Preview

Научно-практическая ревматология

Расширенный поиск

Головная боль, эпилептические припадки, когнитивные расстройства и цереброваскулярные заболевания как самые распространенные нейропсихические синдромы при системной красной волчанке

https://doi.org/10.14412/1995-4484-2014-222-227

Полный текст:

Аннотация

Нервная система часто вовлекается в патологический процесс при системной красной волчанке (СКВ). Нейропсихическая СКВ включает комплекс синдромов. Самыми распространенными являются головная боль, эпилептические припадки, когнитивные расстройства, цереброваскулярные заболевания. Патогенети- ческие механизмы развития нейропсихических синдромов различны. Диагностические и терапевтические стратегии должны быть индивидуализированы для заболевания и пациента. В данной статье будут представ- лены литературные и наши данные по основным наиболее часто встречающимся нейропсихическим син- дромам, развивающимся на фоне СКВ. 

Об авторе

Н. В. Пизова
ГБОУ ВПО «Ярославская государственная медицинская академия» Минздрава России, Ярославль, Россия
Россия


Список литературы

1. Иванова ММ. Системная красная волчанка. Клиника, диагностика и лечение. Клиническая ревматология. 1995;(1):2–19. [Ivanova MM. Systemic lupus erythematosus. Clinic, diagnostics and treatment. Klinicheskaya revmatologiya. 1995;(1):2–19. (In Russ.)]

2. Иванова ММ. ЦНС-люпус: проблемы и достижения (результаты 10-летнего клинико-инструментального исследования) (лекция). Терапевтический архив. 2001;73(5):25–9. [Ivanova MM. TsNS-lyupus: problems and achievements (results of 10 years' kliniko-tool research) (lecture). Terapevticheskii arkhiv. 2001;73(5):25–9. (In Russ.)]

3. Насонова ВА, Бунчук НВ, редакторы. Ревматологические болезни. Руководство для врачей. Москва: Медицина; 1997. 520 с. [Nasonova VA, Bunchuk NV, editors. Revmatologicheskie bolezni. Rukovodstvo dlya vrachei. [Rheumatologic diseases. The management for doctors]. Moscow: Meditsina; 1997. 520 p.]

4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythemato- sus. Arthritis Rheum. 1997;40(9):1725. DOI: http://dx.doi.org/10.1002/art.1780400928.

5. Kassan SS, Lockshin MD. Central nervous system lupus erythe- matosus. The need for classification. Arthritis Rheum. 1979;22(12):1382–5. DOI: http://dx.doi.org/10.1002/art.1780221210.

6. Пизова НВ. Неврологические и психические расстройства при системной красной волчанке. Журнал неврологии

7. и психиатрии им. С.С. Корсакова. 2010;110(8):76–83. [Pizova NV. Neuropsychiatric disorders in systemic lupus erythematosus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2010;110(8):76–83. (In Russ.)]

8. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a com- parison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore). 2003;82(5):299–308. DOI: http://dx.doi.org/10.1097/01.md.0000091181.93122.55.

9. Ainiala H, Hietaharju A, Loukkola J, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45(5):419–23. DOI: http://dx.doi.org/10.1002/1529- 0131(200110)45:5<419::AID-ART360>3.0.CO;2-X.

10. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syn- dromes in lupus. Prevalence using standardized definitions. Neurology. 2002;58(8):1214–20. DOI:

11. http://dx.doi.org/10.1212/WNL.58.8.1214.

12. Hanly JG, Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol. 2005;19(5):799–821. DOI:

13. http://dx.doi.org/10.1016/j.berh.2005.04.003.

14. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore). 1971;50(2):85–95. DOI: http://dx.doi.org/10.1097/00005792- 197103000-00001.

15. Feng PH, Cheah PS, Lee YK. Mortality in systemic lupus erythe- matosus. A 10-year review. Br Med J. 1973;4(5896):772–4. DOI: http://dx.doi.org/10.1136/bmj.4.5895.772.

16. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25(6):606–11. DOI: http://dx.doi.org/10.1002/art.1780250601.

17. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus. II. Causes of death. Arthritis Rheum. 1982;25(6):612–7. DOI: http://dx.doi.org/10.1002/art.1780250602.

18. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599–608. DOI: http://dx.doi.org/10.1002/1529- 0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F.

19. Файзулина ДЛ, Шпрах ВВ. Поражение нервной системы при системной красной волчанке. Сибирский медицинский журнал (Иркутск). 2009;90(7):5–10. [Faizulina DL, Shprah VV. The damage of nervous system in lupus erythematosus. Sibirskii meditsinskii zhurnal (Irkutsk). 2009;90(7):5–10. (In Russ.)]

20. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Systemic lupus international collaborating clinics. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an inter- national inception cohort study. Arthritis Rheum. 2007;56(1):265–73. DOI: http://dx.doi.org/10.1002/art.22305.

21. Petri M, Naqibuddin M, Carson KA, et al. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol. 2008;35(9):1776–81. Epub 2008 Jul 15.

22. Unterman A, Nolte JE, Boaz M, et al. Neuropsychiatric syn- dromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41(1):1–11. DOI: 10.1016/j.semarthrit.2010.08.001. Epub 2010 Oct 20.

23. Robert M, Sunitha R, Thulaseedharan NK. Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India. Neurol India. 2006;54(1):75–7. DOI: http://dx.doi.org/10.4103/0028-3886.24713.

24. Appenzeller S, Costallat L. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ dam- age. Cephalalgia. 2004;24(12):1024–30. DOI: http://dx.doi.org/10.1111/j.1468-2982.2004.00785.x.

25. Glanz BI, Venkatesan A, Schur PH, et al. Prevalence of migraine in patients with systemic lupus erythematosus. Headache. 2001;41(3):285–9. DOI: http://dx.doi.org/10.1046/j.1526- 4610.2001.111006285.x.

26. Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004;127(5):1200–9. DOI: http://dx.doi.org/10.1093/brain/awh146.

27. Lessa B, Santana A, Lima I, et al. Prevalence and classification of headache in patients with systemic lupus erythematosus. Clin Rheumatol. 2006;25(6):850–3. Epub 2006 Jan 26. DOI: http://dx.doi.org/10.1007/s10067-005-0186-x.

28. Fernandez-Nebro A, Palacios-Munoz R, Gordillo J, et al. Chronic or recurrent headache in patients with systemic lupus ery- thematosus: a case control study. Lupus. 1999;8(2):151–6. DOI: http://dx.doi.org/10.1191/096120399678847443.

29. Goh R, Heritzen A, Tan CT, Hoh MC. Headaches and systemic lupus erythematosus: is there an entity of «lupus headache»? Neurol J Southeast Asia. 1997;(2):51–6.

30. Sfikakis PP, Mitsikostas DD, Manoussakis MN, et al. Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol. 1998;37:300–3. DOI: http://dx.doi.org/10.1093/rheumatol- ogy/37.3.300.

31. Amit M, Molad Y, Levy O, Wysenbeek AJ. Headache in systemic lupus erythematosus and its relation to other disease manifesta- tions. Clin Exp Rheumatol. 1999;17(4):467–70.

32. Isenberg DA, Meyrick-Thomas D, Snaith ML, et al. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis. 1982;41(1):30–2. DOI: http://dx.doi.org/10.1136/ard.41.1.30.

33. Appenzeller O. Return to the headache in systemic lupus erythe- matosus using modern technology. Cephalalgia. 1998;18(4):171–2. DOI: http://dx.doi.org/10.1046/j.1468-2982.1998.1804171-3.x.

34. Laversuch CJ, Brown MM, Clifton A, Bourke BE. Cerebral venous thrombosis and acquired protein S deficiency:

35. an uncommon cause of headache in systemic lupus erythematosus. Br J Rheumatol. 1995;34(6):572–5. DOI: http://dx.doi.org/10.1093/rheumatology/34.6.572.

36. Vidailhet M, Piette JC, Wechsler B, et al. Cerebral venous throm- bosis in systemic lupus erythematosus. Stroke. 1990;21(8):1226–31. DOI: http://dx.doi.org/10.1161/01.STR.21.8.1226.

37. Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke. 1989;20(5):583–91. DOI: http://dx.doi.org/10.1161/01.STR.20.5.583.

38. Nakai Y, Hyodo A, Yanaka K, et al. Distal superior cerebellar artery aneurysm in a patient with systemic lupus erythematosus: case report. Surg Neurol. 2000l;54(1):73–6. DOI: http://dx.doi.org/10.1016/S0090-3019(00)00261-5.

39. Пизова НВ. Системная красная волчанка и эпилепсия. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010;(3 приложение 2):35–8. [Pizova NV. Sistemnaya krasnaya volchanka i epilepsiya. Zhurnal nevrologii i psikhiatrii im.

40. S.S. Korsakova. 2010;(3 Suppl 2):35–8. (In Russ.)]

41. Mayes B, Brey R. Evaluation and treatment of seizures in patients

42. with systemic lupus erythematosus. J Clin Rheumatol. 1996;2(6):336–45. DOI: http://dx.doi.org/10.1097/00124743- 199612000-00007.

43. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature inves- tigation. Rheumatology (Oxford). 2002;41(6):605–18. DOI: http://dx.doi.org/10.1093/rheumatology/41.6.605.

44. Herranz MT, Rivier G, Khamashta MA, et al. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum. 1994;37(4):568–71. DOI: http://dx.doi.org/10.1002/art.1780370418.

45. Mackworth-Young CG, Hughes GR. Epilepsy: an early symptom of SLE. J Neurol Neurosurg Psychiatry. 1985;48(2):185. DOI: http://dx.doi.org/10.1136/jnnp.48.2.185.

46. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001;28(4):766–71.

47. Kampylafka EI, Alexopoulos H, Kosmidis ML, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One. 2013;8(2):e55843. DOI: 10.1371/journal.pone.0055843. Epub 2013 Feb 12.

48. Aarli J. Epilepsy and the immune system. Arch Neurol. 2000;57(12):1689–92. DOI: http://dx.doi.org/10.1001/arch- neur.57.12.1689.

49. Liou HH, Wang CR, Chen CJ, et al. Elevated levels of anticardi- olipin antibodies and epilepsy in lupus patients. Lupus. 1996;5(4):307–12. DOI: http://dx.doi.org/10.1177/096120339600500412.

50. Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neu- ropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008;58(4):1130–5. DOI: 10.1002/art.23399.

51. Kozora E, West SG, Maier SF, et al. Antibodies against N-methyl- D-aspartate receptors in patients with systemic lupus erythemato- sus without major neuropsychiatric syndromes. J Neurol Sci. 2010;295(1–2):87–91. DOI: 10.1016/j.jns.2010.04.016. Epub 2010 May 23.

52. Postal M, Costallat LTL, Appenzeller S. Neuropsychiatric mani- festations in systemic lupus erythematosus: Epidemiology, patho- physiology and management. CNS Drugs. 2011;25(9):721–36. DOI: 10.2165/11591670-000000000-00000.

53. Yoshio T, Hirata D, Onda K, et al. Antiribosomal P protein anti- bodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2005;32(1):34–9.

54. Andrade RM, Alarcon GS, Gonzalez LA, et al.; LUMINA Study Group. Seizures in patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis. 2008;67(6):829–834. Epub 2007 Sep 17. DOI: http://dx.doi.org/10.1136/ard.2007.077594.

55. Malik S, Bruner GR, Williams-Weese C, et al. Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients. Lupus. 2007;16(11):863–6. DOI: http://dx.doi.org/10.1177/0961203307083365.

56. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis. 1986;174(6):357–64. DOI: http://dx.doi.org/10.1097/00005053- 198606000-00008.

57. Carlomagno S, Migliaresi S, Ambrosone L, et al. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol. 2000;247(4):273–9. DOI: http://dx.doi.org/10.1007/s004150050583.

58. Glanz BI, Slonim D, Urowitz MB, et al. Pattern of neuropsycho- logical dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10:232–8.

59. Hanly JG, Fisk JD, Sherwood G, et al. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol. 1992;19(4):562–7.

60. Hay EM, Black D, Huddy A, et al. Psychiatric disorder and cog- nitive impairment in systemic lupus erythematosus. Arthritis Rheum. 1992;35(4):411–6. DOI: http://dx.doi.org/10.1002/art.1780350409.

61. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cogni- tive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1996;39(12):2035–45. DOI:http://dx.doi.org/10.1002/art.1780391213.

62. Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern

63. Chinese patients with systemic lupus erythematosus. Medicine (Baltimore). 2006;85(4):221–8. DOI: http://dx.doi.org/10.1097/01.md.0000231955.08350.1b.

64. McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythemato- sus. Neurology. 2005;64(2):297–303. DOI: http://dx.doi.org/10.1212/01.WNL.0000149640.78684.EA.

65. Gladman DD, Urowitz MB, Slonim D, et al. Evaluation of pre- dictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. J Rheumatol. 2000;27(10):2367–71.

66. Carbotte RM, Denburg SD, Denburg JA. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol. 1995;22(5):863–7.

67. Rogers MP, Waterhouse E, Nagel JS, et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cogni- tive and other minor neuropsychiatric symptoms: a pilot study. Lupus. 1992;1(4):215–9. DOI: http://dx.doi.org/10.1177/096120339200100404.

68. Tomietto P, Annese V, D'Agostini S, et al. Neuropsychological tests, MRI and SPECT in the evaluation of CNS involvement in SLE. Reumatismo. 2003;55(3):171–80.

69. Waterloo K, Omdal R, SjЪholm H, et al. Neuropsychological dys- function in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol. 2001;248(7):595–602. DOI: http://dx.doi.org/10.1007/s004150170138.

70. Shucard JL, Gaines JJ, Ambrus J Jr, Shucard DW. C-reactive pro- tein and cognitive deficits in systemic lupus erythematosus. Cogn Behav Neurol. 2007;20(1):31–7. DOI: http://dx.doi.org/10.1097/WNN.0b013e31802e3b9a.

71. Asherson RA, Mercey D, Phillips G, et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: associa- tion with antiphospholipid antibodies. Ann Rheum Dis. 1987;46(8):605–11. DOI: http://dx.doi.org/10.1136/ard.46.8.605.

72. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum. 1999;42(4):728–34. DOI: http://dx.doi.org/10.1002/1529-0131(199904)42:4<728::AID- ANR16>3.0.CO;2-O.

73. Long AA, Denburg SD, Carbotte RM, et al. Serum lymphocyto- toxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis. 1990;49(4):249–53. DOI: http://dx.doi.org/10.1136/ard.49.4.249.

74. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and anti-neuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum. 1998;41(10):1819–27. DOI: http://dx.doi.org/10.1002/1529-0131(199810)41:10<1819::AID- ART14>3.0.CO;2-Y.

75. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E, et al. The clini- cal relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis. 2000;59(2):99–104. DOI: http://dx.doi.org/10.1136/ard.59.2.99.

76. Kitagawa Y, Gotoh F, Koto A, Okayasu H. Stroke in systemic lupus erythematosus. Stroke. 1990;21(11):1533–9. DOI: http://dx.doi.org/10.1161/01.STR.21.11.1533.

77. Krishnan E. Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med. 2005;118(12):1415. DOI: http://dx.doi.org/10.1016/j.amjmed.2005.05.026.

78. Ward MM. Premature morbidity from cardiovascular and cere- brovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42:338–46. DOI: http://dx.doi.org/10.1002/1529-0131(199902)42:2<338::AID-

79. ANR17>3.0.CO;2-U.

80. Bessant R, Duncan R, Ambler G, et al. Prevalence of convention-

81. al and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Rheum. 2006;55(6):892–9. DOI: http://dx.doi.org/10.1002/art.22343.

82. Mitsias P, Levine SR. Large vessel occlusive disease in systemic lupus erythematosus. Neurology. 1994;44(3 Pt 1):385–93. DOI: http://dx.doi.org/10.1212/WNL.44.3_Part_1.385.

83. Zö ller B, Li X, Sundquist J, Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012;12:41. DOI: 10.1186/1471-2377-12- 41.

84. Booth S, Chohan S, Curran JC, et al. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythe- matosus. Arthritis Rheum. 2007;57(5):845–50. DOI: http://dx.doi.org/10.1002/art.22766.

85. Gonzales-Portillo F, McIntyre JA, Wagenknecht DR, et al. Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease. J Stroke Cerebrovasc Dis. 2001;10(5):222–6. DOI: http://dx.doi.org/10.1053/jscd.2001.29818.

86. Blohorn A, Guegan-Massardier E, Triquenot A, et al. Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients. Cerebrovasc Dis. 2002;13(3):156–62. DOI: http://dx.doi.org/10.1159/000047769.

87. Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology. 2002;41(6):619–30. DOI: http://dx.doi.org/10.1093/rheumatol- ogy/41.6.619.

88. Calvo-Alen J, Alarcon GS, Tew MB, et al.; LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannosebinding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum. 2006;54(6):1940–5. DOI: http://dx.doi.org/10.1002/art.21787.

89. Goel D, Reddy SR, Sundaram C, et al. Active necrotizing cerebral vasculitis in systemic lupus erythematosus. Neuropathology. 2007;27(6):561–5. DOI: http://dx.doi.org/10.1111/j.1440- 1789.2007.00813.x.

90. Conen KL, Jeanneret C, Hecker B, et al. Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: arteritis or atherosclerosis? Arthritis Rheum. 2006;54(3):908–13. DOI: http://dx.doi.org/10.1002/art.21656.

91. Mikdashi J, Handwerger B, Langenberg P, et al. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemicstroke and stroke severity in systemic lupus erythemato- sus. Stroke. 2007;38(2):281–5. DOI: http://dx.doi.org/10.1161/01.STR.0000254476.05620.14. Epub 2007 Jan 11.

92. Gao N, Wang ZL, Li MT, et al. Clinical characteristics and risk factors of intracranial hemorrhage in systemic lupus erythemato- sus. Lupus. 2013;22(5):453–60. DOI: 10.1177/0961203313477226.

93. Donders RC, Kappelle LJ, Derksen RH, et al. Transient monocu- lar blindness and antiphospholipid antibodies in systemic lupus erythematosus. Neurology. 1998;51(2):535–40. DOI: http://dx.doi.org/10.1212/WNL.51.2.535.

94. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid syndrome in systemic lupus erythematosus. Medicine. 1989;68(6):353–65.


Для цитирования:


Пизова Н.В. Головная боль, эпилептические припадки, когнитивные расстройства и цереброваскулярные заболевания как самые распространенные нейропсихические синдромы при системной красной волчанке. Научно-практическая ревматология. 2014;52(2):222-227. https://doi.org/10.14412/1995-4484-2014-222-227

For citation:


Pizova N.V. HEADACHE, SEIZURES, COGNITIVE DISORDERS, AND CEREBROVASCULAR DISEASES AS THE MOST COMMON NEUROPSYCHIC SYNDROMES IN SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatology Science and Practice. 2014;52(2):222-227. (In Russ.) https://doi.org/10.14412/1995-4484-2014-222-227

Просмотров: 813


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)